Skip to content
Home/Companies/Biotech/Invitris
IN

Invitris

Biotech·Germany·Active·3yr hold

Invitris is a biotech company, headquartered in Germany.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Invitris?

Invitris is currently owned by 10x Founders through 10x Founders Fund I (2022 vintage), since 2023.

Hand-verified · updated 2026-07-03

10x Founders
Investor
10x Founders
10x Founders Fund I · 2022 · VC

Key facts

HQGermany
SectorBiotech
StatusActive

More from 10x Founders Fund I

Other portfolio companies in the same fund.

Arlequin
Active
Deep TechFrance· 2025
Cocrafter
Active
SaaSGermany· 2025
Lyceum
Active
Deep TechGermany· 2025
Noah
Active
FintechUnited Kingdom· 2025
Artisan
Active
SoftwareUnited States· 2024
Beyond Presence
Active
SoftwareGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings